|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-8-24
|
|
pubmed:abstractText |
Patients with comorbidities have an increased risk of ulcer rebleeding, especially within the 28 days after endoscopic therapy. Omeprazole infusion can prevent rebleeding after endoscopic therapy in patients with peptic ulcer bleeding. However, the optimal duration is uncertain, especially for those patients with comorbidities.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1097-6779
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19500787-Aged,
pubmed-meshheading:19500787-Aged, 80 and over,
pubmed-meshheading:19500787-Comorbidity,
pubmed-meshheading:19500787-Confidence Intervals,
pubmed-meshheading:19500787-Dose-Response Relationship, Drug,
pubmed-meshheading:19500787-Drug Administration Schedule,
pubmed-meshheading:19500787-Duodenal Ulcer,
pubmed-meshheading:19500787-Education, Medical, Continuing,
pubmed-meshheading:19500787-Female,
pubmed-meshheading:19500787-Follow-Up Studies,
pubmed-meshheading:19500787-Hemostasis, Endoscopic,
pubmed-meshheading:19500787-Humans,
pubmed-meshheading:19500787-Infusions, Intravenous,
pubmed-meshheading:19500787-Kaplan-Meier Estimate,
pubmed-meshheading:19500787-Male,
pubmed-meshheading:19500787-Middle Aged,
pubmed-meshheading:19500787-Omeprazole,
pubmed-meshheading:19500787-Peptic Ulcer Hemorrhage,
pubmed-meshheading:19500787-Probability,
pubmed-meshheading:19500787-Prospective Studies,
pubmed-meshheading:19500787-Recurrence,
pubmed-meshheading:19500787-Risk Assessment,
pubmed-meshheading:19500787-Severity of Illness Index,
pubmed-meshheading:19500787-Statistics, Nonparametric,
pubmed-meshheading:19500787-Stomach Ulcer,
pubmed-meshheading:19500787-Survival Rate,
pubmed-meshheading:19500787-Time Factors,
pubmed-meshheading:19500787-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
|
|
pubmed:affiliation |
Institute of Clinical Medicine, Medical College, National Cheng Kung University, Tainan, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
